One-Per-Day Tablets

Life Extension

$23.00 

Save 15% forever Order Direct!

Sign up on next page to complete order

The ultimate one-a-day multivitamin

Huge numbers of Americans take a multivitamin, but the potencies of the individual nutrients are usually so trivial that no health benefit is derived. The ultra-low cost of One-Per-Day makes it one of the great bargains on the dietary supplement marketplace.

One-Per-Day now contains three potent forms of selenium (SelenoExcell®, Se-methyl-selenocysteine, and sodium selenite). Also included is apigenin, a powerful bioflavonoid found in many vegetables and fruits which boosts cell protection.

One-Per-Day Tablets provide Crominex® 3+, a highly stable and biologically active form of chromium blended with Capros® Amla and PrimaVie® Shilajit.1 When used as part of a healthy diet, chromium plays a vital role in maintaining healthy blood sugar levels in those within normal range. One-Per-Day Tablets additionally contain alpha-lipoic acid, the universal antioxidant that helps boost glutathione levels already in normal range.

Life Extensions One-Per-Day formula contains the form of vitamin D known as cholecalciferol (vitamin D3). It also contains bioactive forms of vitamin B2, vitamin B6 and folate, zinc citrate and natural mixed tocopherols.

Compared to Centrum® Silver® Adults 50+, One-Per-Day Tablets provide about:

  • 8 times more vitamin C
  • 4 times more vitamin D
  • 2 times more vitamin E
  • 10 times more biotin
  • 20 times more boron
  • 10 times more selenium
  • 25 times more vitamin B6
  • 50 times more vitamin B1
  • 12 times more vitamin B12
  • More than twice as much niacin, zinc, and many other nutrients.

Life Extension®’s One-Per-Day contains 5-methyltetra-hydrofolate (5-MTHF), the active form of folate that is up to 7 times more bioavailable than folic acid. This greater bioavailability is especially important in people with a genetic enzyme deficiency since it requires no conversion to become metabolically active.

References

  1. Int J Diabetes Dev Ctries. 2010;30(3): 153-161.